May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Clinical Characteristics of Patients With Retinal Degeneration Caused by Biallelic Mutation of RLBP1
Author Affiliations & Notes
  • Z. Li
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
  • P. Moradi
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
  • D. Mackay
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
  • A. G. Robson
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
    Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, United Kingdom
  • G. E. Holder
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
    Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, United Kingdom
  • A. R. Webster
    Institute of Ophthalmology, UCL, 11-43 Bath Street, London, EC1V 9EL, United Kingdom
    Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, United Kingdom
  • Footnotes
    Commercial Relationships  Z. Li, None; P. Moradi, None; D. Mackay, None; A.G. Robson, None; G.E. Holder, None; A.R. Webster, None.
  • Footnotes
    Support  British Retinitis Pigmentosa Society, EVI-Genoret and Foundation Fighting Blindness.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2163. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Z. Li, P. Moradi, D. Mackay, A. G. Robson, G. E. Holder, A. R. Webster; The Clinical Characteristics of Patients With Retinal Degeneration Caused by Biallelic Mutation of RLBP1. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2163.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report the clinical phenotype in 2 families segregating retinal degeneration consequent upon mutation of RLBP1, the gene encoding cellular retinaldehyde-binding protein (CRALBP) a water soluble protein that binds 11-cis retinoids in the retinal pigment epithelium.

Methods: : Patients attending clinics at Moorfields Eye Hospital with retinal signs of either fundus albipunctatus (FA) or retinal gyrate atrophy were ascertained and examined. Blood was taken for plasma ornithine estimation, and DNA was extracted. The coding sequence of RDH5 and RLBP1 was sequenced.

Results: : Family A consisted of three affected female siblings diagnosed with gyrate atrophy, had normal plasma ornithine levels.Family B, consisting of one female and two male siblings had punctate white dots on fundoscopy and a normal coding sequence for RDH5. All affected individuals had night blindness from early childhood. Older individuals had a slowly progressive loss of peripheral field, with loss of central acuity in the 6th to 7th decade. There was widespread loss of RPE and choroid in the 5th to 7th decades. Electroretinography (ERG) in the family B indicated generalized retinal dysfunction with a rod-cone pattern. After overnight dark adaptation, rod-mediated ERGs showed some improvement but did not normalize. Family A segregated, in trans, a previously published mutation in intron 4 (IVS4+2 T>C), and a novel mutation in intron 3 (IVS3+2 delT). Affected members of family B were homozygous for a novel 12bp deletion in exon 5 (F96_F99del).

Conclusions: : RLBP1 mutation causes early-onset or congenital night blindness and a slowly progressive retinal degeneration that resembles fundus albipunctatus in the early stages and gyrate atrophy in the late stages of the disease. The failure of rod ERGs to normalize following extended dark adaptation differs from fundus albipunctatus (RDH5 mutation), where rod ERG normalization occurs.

Keywords: retinal degenerations: hereditary • genetics • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×